caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1023282795

Jorge RiveraM.D.

OphthalmologyMayaguez, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$245
Payment records
2
By payment type
Food and Beverage$245
PRESCRIBING · PART D · 2024
Total Rx claims
18,328
Beneficiaries
—
Total drug cost
$1.9M
Distinct drugs
30
Brand share
41.7%
Top prescribed drugs
Latanoprost5,137 claims
Bimatoprost3,501 claims
Dorzolamide Hcl/Timolol Maleat1,673 claims
Prednisolone Acetate977 claims
Brinzolamide/Brimonidine Tart970 claims
REFERRAL NETWORK

Where Jorge Rivera's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratorio Clinico Irizarry Guasch Inc
Clinical Laboratory · Mayaguez, PR
1221
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
197
Unique beneficiaries
—
Total services
243
Distinct HCPCS
6
Medicare payment
$10K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 181 Ophthalmology providers in PR — above median (cohort median 193).